Tennessee Execution of Christa Pike Fails After Two Lethal Injections, Inmate Hospitalized

A convicted murderer in Tennessee remains alive and under emergency medical care after a scheduled execution by lethal injection failed to end her life, authorities have confirmed. Christa Pike, 50, was declared still breathing on Wednesday evening after receiving two syringes of the drug pentobarbital, according to statements from her legal team. The Tennessee Department of Correction said she was transported to an off-site medical facility, where her lawyers described her as undergoing "life-saving measures." Her condition as of Thursday morning was not immediately clear.

The failure marks an extraordinary turn in a capital case that had already drawn intense legal scrutiny. Pike had been sentenced to death in 1996 for the torture and murder of 19-year-old Colleen Slemmer, a crime she committed alongside her then-boyfriend, Tadaryl Shipp. Her execution had been cleared by the US Supreme Court at the eleventh hour on Wednesday after a protracted legal battle, allowing the state to proceed with the injection just hours before the death warrant was set to expire.

According to accounts from her attorneys, Pike received the pentobarbital in two separate doses, yet the drug did not stop her heartbeat. Witnesses or those in proximity to the execution chamber reported that she could still be heard snoring, suggesting she remained in a deeply sedated but living state. The Tennessee Department of Correction issued a statement defending its procedure, asserting that "the protocol does not allow for additional procedures beyond what was carried out this evening." The department did not immediately explain why the dosage proved non-fatal, and state officials have yet to clarify whether they will attempt a second execution.

Medical experts have offered preliminary theories about what may have gone wrong. Dr Joel Zivot, a professor at Emory University School of Medicine who said he was retained by Pike's legal team as a medical expert, told the BBC that Pike likely never reached a sufficient concentration of pentobarbital in her bloodstream to trigger the apnoea and cardiovascular collapse that lethal injection is designed to produce. Drugs can fail to achieve the intended effect for a variety of reasons, including if the substance has degraded over time, a claim Pike's attorneys have made. The Tennessee Department of Correction has not directly addressed the degradation allegation, but issued a broad defence of its method, stating that "the lethal injection chemical in the protocol has consistently been effective."

The incident has raised urgent questions about Pike's prognosis and the possibility of lasting harm. In emailed comments to the BBC, Zivot warned that because of the delay in beginning resuscitation efforts, "it's very possible that as a consequence of the delay of the beginning of resuscitation she will have a brain injury." Her exact health status remained unclear on Thursday morning. A third-party review has been ordered by Tennessee Governor Bill Lee, who also announced that the state's last remaining scheduled execution of the year will not go ahead as planned.

Reaction to the failed execution has been swift and sharply divided. May Martinez, the mother of Colleen Slemmer, who had long pushed for Pike's execution to be carried out, told NBC News that the events amounted to "a mess." Opponents of capital punishment seized on the development as evidence of the inherent problems with lethal injection. Maya Foa, chief executive of the international legal organisation Reprieve, said: "We cannot know exactly what went wrong, because so much happened behind a curtain – lethal injection relies on secrecy at every stage, to hide the violence of the state taking a human life."

Pentobarbital, the drug at the centre of the case, is a potent sedative that slows the nervous system. It is sometimes used therapeutically by doctors to treat certain conditions, but in high doses it is employed in lethal injections to cause death. Its use in executions drew renewed scrutiny last year after a federal government review conducted under President Joe Biden raised concerns about the drug's potential for "unnecessary pain and suffering." The Biden administration banned its use in federal executions, but that decision did not bind individual states such as Tennessee, which retain the authority to choose their own execution methods. In recent years, states have struggled to obtain some drugs required for lethal injections because pharmaceutical companies have opposed the use of their products for capital punishment.

Wednesday's failure is not the first time Tennessee has encountered problems carrying out an execution in 2026. In May, the scheduled execution of Tony Carruthers—convicted of kidnapping and murdering three people in 1994—was postponed after staff could not locate a suitable vein to administer the lethal injection. Governor Lee granted Carruthers a one-year reprieve. The broader national picture is similarly troubling for supporters of the death penalty. In 2022, more than a third of executions carried out in the United States were classified as botched or highly problematic, according to the Death Penalty Information Center, an organisation that compiles statistics and research on capital punishment but does not take a formal position on its morality.

Authorities have not indicated whether they intend to make a second attempt to execute Pike, though there is historical precedent for states seeking to carry out an execution again after an initial failure. Meanwhile, Shipp, Pike's co-defendant and boyfriend at the time of the murder, remains in prison. He was 17 years old when Slemmer was killed, and under state law he was spared the death penalty. The failed execution of Pike has renewed attention not only on the specific circumstances of her case but on the wider debate over lethal injection, state secrecy, and the possibility of cruel and unusual punishment when an execution does not proceed as intended.